Showing 1501-1510 of 5771 results for "".
- Atia Vision Announces Presentation of First-In-Human Results with OmniVu IOL System at ASCRShttps://modernod.com/news/atia-vision-announces-presentation-of-first-in-human-results-with-their-novel-intraocular-lens-at-ascrs/2481598/Atia Vision announced the first clinical data on the patented OmniVu IOL System will be presented at the 2023 Annual Meeting of the American Society of Cataract Refractive Surgery (ASCRS) in San Diego, California. First-in-human findings will be shared by&n
- Alcon Announces its Largest Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivityhttps://modernod.com/news/alcon-announces-its-largest-scientific-presence-at-ascrs-2023-and-expands-image-guided-connectivity/2481588/Alcon announced its surgical ophthalmic presence at the American Society of Cataract and Refractive Surgery (ASCRS) 2023 annual meeting, taking place May 5-8 in San Diego, and stated that its innovations will be featured in more studies than ever in its history.[1] Alcon ASCRS even
- Aurion Biotech to Present Clinical Trial Results at the 2023 ASCRS Annual Meetinghttps://modernod.com/news/aurion-biotech-to-present-clinical-trial-results-at-the-2023-ascrs-annual-meeting/2481586/Aurion Biotech announced several presentations during the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting to be held May 5-8, 2023 in San Diego, California. At Eyecelerator and ASCRS 2023, data will be presented from the comp
- ViaLase to Present Clinical Data at the 2023 ASCRS Annual Meetinghttps://modernod.com/news/vialase-to-present-clinical-data-at-the-2023-ascrs-annual-meeting/2481582/ViaLase announced that it will present first-in-human clinical data and a technology overview during the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting to be held May 5-8, 2023 in San Diego, California. Presentati
- Medical Consulting Group and Corcoran Consulting Group Announce Mergerhttps://modernod.com/news/medical-consulting-group-and-corcoran-consulting-group-announce-merger/2481571/Medical Consulting Group (MCG), a provider of consulting services to ophthalmic practices and companies, and Corcoran Consulting Group (CCG), a company specializing in billing, coding, and reimbursement issues for ophthalmology and optometry practices, today announced a definitive merger agreemen
- Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at ASCRShttps://modernod.com/news/bausch-lomb-announces-the-presentation-of-new-scientific-data-on-products-and-pipeline-programs-at-ascrs/2481566/Bausch + Lomb announced the presentation of 21 podium presentations and four poster presentations related to the company’s products and pipeline programs during the A
- Atsena Therapeutics Announces Positive 6-month Data from Ongoing Phase 1/2 Clinical Trial of ATSN-101 in Patients with LCA1https://modernod.com/news/atsena-therapeutics-announces-positive-6-month-data-from-ongoing-phase-12-clinical-trial-of-atsn-101-in-patients-with-lca1/2481563/Atsena Therapeutics announced positive 6-month safety and efficacy data from the ongoing phase 1/2 clinical trial of ATSN-101, the company’s investigational gene therapy for the treatment of GUCY2D-associated Leber congenital amaurosis (LCA1). The data were presented by Chris
- Iveric Bio Announces New Functional Vision Loss Reduction Data from Avacincaptad Pegol GATHER Trialshttps://modernod.com/news/iveric-bio-announces-new-functional-vision-loss-reduction-data-from-avacincaptad-pegol-gather-trials/2481557/Iveric bio announced new findings from exploratory analyses of data for avacincaptad pegol (ACP), which were presented at the 2023 annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in New Orleans. A post-hoc analysis from the GATHER1 and GATHER2
- Bausch + Lomb Announces U.S. Launch of StableVisc Cohesive Ophthalmic Viscosurgical Device and TotalVisc Viscoelastic Systemhttps://modernod.com/news/bausch-lomb-announces-us-launch-of-stablevisc-cohesive-ophthalmic-viscosurgical-device-and-totalvisc-viscoelastic-system/2481555/Bausch + Lomb announced the US launch of StableVisc cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc Viscoelastic System. StableVis
- Iridex Announces US Launch of Next Generation PASCAL Laser with MicroPulsehttps://modernod.com/news/iridex-launches-next-gen-pascal-laser-with-micropulse-in-us/2481542/Iridex announced the full market launch of the next generation Iridex PASCAL platform. First offered in limited release in late 2022, the PASCAL is designed to provide an advanced technology package combining fast and precise pattern scanning capabilities, Endpoint Management Techn